Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer.

JAMA Oncol · 2025 · PMC11843371 · PMID 39724105

Europe PMC DOI

hedged sentence

0.4500

closest p · 9.0× alpha

0.4500

boldest claim

The sentences

a nonsignificant trendP = .45not close (p > 0.1)

Considering statistical power, PFS and ORR results were consistent in the validation subcohorts (FPUCBM and ICL), except the AUMC dataset showed a nonsignificant trend toward higher median PFS (7.2 vs 3.6 months; P = .45) associated with the Deep-IO score (eFigure 11 in Supplement 1 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.